Skip to main content

Advertisement

SpringerLink
Log in

The Challenge of Triple Negative Breast Cancers

  • Editorial
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Andersen E. The role of estrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002;4:197–201.

    Article  Google Scholar 

  2. Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol. 2010;7:683–92.

    Article  PubMed  Google Scholar 

  3. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100(14):8418–23 Epub 2003 Jun 26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Vaidyanathan K, Kumar P, Reddy CO, Deshmane V, Somasundaram K, Mukherjee G. “ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women”. Indian J Cancer. 2010;47(1):14–21.

    Google Scholar 

  5. Du X, Li XQ, Li L, Xu YY, Feng YM. Breast Cancer Res Treat. The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis. 2013;138(1):59–67. doi:10.1007/s10549-013-2432-2.Epub2013Feb10.

    CAS  Google Scholar 

  6. Denkert C, Loibl S, Kronenwett R, Budczies J, von Törne C, Nekljudova V, et al. RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy. Ann Oncol. 2013;24(3):632–9. doi:10.1093/annonc/mds339.Epub2012Nov6.

    Article  CAS  PubMed  Google Scholar 

  7. Bastien RR, Rodríguez-Lescure Á, Ebbert MT, Prat A, Munárriz B, Rowe L, et al. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics. 2012;4(5):44. doi:10.1186/1755-8794-5-44.

    Article  Google Scholar 

  8. Liu NQ, Stingl C, Look MP, Smid M, Braakman RB, De Marchi T, et al. Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer. J Natl Cancer Inst. 2014;106(2):djt376. doi:10.1093/jnci/djt376.Epub2014Jan7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept of Biochemistry, Pushgpagiri Institute of Medical Science & Research Center, Tiruvalla, Kerala, 689 101, India

    Kannan Vaidyanathan

Authors
  1. Kannan Vaidyanathan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kannan Vaidyanathan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaidyanathan, K. The Challenge of Triple Negative Breast Cancers. Ind J Clin Biochem 29, 267–268 (2014). https://doi.org/10.1007/s12291-014-0453-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-014-0453-1

Search

Navigation